ResearcherRenmin Hospital of Wuhan UniversityActive in the last 2 years

Luojun Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4694-8422; OpenAlex author ID A5080295309. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. Co-author DOI 10.1016/j.canlet.2024.216696 ↗
Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer. First author DOI 10.3389/fgene.2020.612196 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qibin Song · 2 shared papers, 2020–2024 · strength 0.39
- Paper Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. DOI 10.1016/j.canlet.2024.216696 ↗
- Paper Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer. DOI 10.3389/fgene.2020.612196 ↗
Pingfeng Zhang · 1 shared paper, 2024 · strength 0.23
- Paper Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy. DOI 10.1016/j.canlet.2024.216696 ↗
Hao Zuo · 1 shared paper, 2020 · strength 0.16
- Paper Identification of a Ubiquitination-Related Gene Risk Model for Predicting Survival in Patients With Pancreatic Cancer. DOI 10.3389/fgene.2020.612196 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.